12 research outputs found
Antibacterial Ilicicolinic Acids C and D and Ilicicolinal from <i>Neonectria discophora</i> SNB-CN63 Isolated from a Termite Nest
Ilicicolinic acids A, C, and D (<b>1</b>–<b>3</b>) and ilicicolinal (<b>4</b>)
were isolated from a fungus isolated
from a <i>Nasutitermes corniger</i> nest in French Guiana.
The structures of ilicicolinic acids C and D and ilicicolinal were
elucidated using 1D and 2D NMR spectroscopic data as well as MS data.
Ilicicolinic acids show antibacterial activity <i>in vitro</i>
Antifungal Agents from <i>Pseudallescheria boydii</i> SNB-CN73 Isolated from a <i>Nasutitermes</i> sp. Termite
Defense mutualisms between social
insects and microorganisms have been described in the literature.
The present article describes the discovery of a <i>Pseudallescheria
boydii</i> strain isolated from <i>Nasutitermes</i> sp. The microbial symbiont produces two antifungal metabolites:
tyroscherin and <i>N</i>-methyltyroscherin, a compound not
previously described in the literature. Methylation of tyroscherin
has confirmed the structure of <i>N</i>-methyltyroscherin.
Both compounds are effective antifungal agents with favorable selectivity
indices for <i>Candida albicans</i> and <i>Trichophyton
rubrum</i>
Pseudallicins A–D: Four Complex Ovalicin Derivatives from <i>Pseudallescheria boydii</i> SNB-CN85
The isolation and
complete structural elucidation of four complex
ovalicin analogues, named pseudallicins A–D, from the fungus <i>Pseudallescheria boydii</i> strain SNB-CN85 are described. On
the basis of structural similarities and information from the literature,
a joint biosynthetic pathway for the pseudallicins is proposed
Mucorolactone, a Macrolactone from Mucor sp. SNB-VECD13A, a Fungus Isolated from the Cuticle of a Vespidae Species
The
newly discovered macrolactone, mucorolactone, along with eight known
compounds, was isolated from an ethyl acetate extract of the insect-borne
fungus Mucor sp. All structures were
elucidated using 1D and 2D NMR and MS spectroscopic experiments. Relative
and absolute configurations of the original skeleton of mucorolactone
was deduced from NOESY experiments, from the <sup>13</sup>C NMR chemical
shift calculation based on the DP4 probability method, and from the
comparison of experimental and calculated electronic circular dichroism
spectra
Structurally Diverse Diterpenoids from Sandwithia guyanensis
Bioassay-guided fractionation of
an EtOAc extract of the trunk
bark of Sandwithia guyanensis, using
a chikungunya virus (CHIKV)-cell-based assay, afforded 17 new diterpenoids <b>1</b>–<b>17</b> and the known jatrointelones A and
C (<b>18</b> and <b>19</b>). The new compounds included
two tetranorditerpenoids <b>1</b> and <b>2</b>, a trinorditerpenoid <b>3</b>, euphoractines P-W (<b>4</b>–<b>11</b>), and euphactine G (<b>13</b>) possessing the rare 5/6/7/3
(<b>4</b>–<b>7</b>), 5/6/6/4 (<b>8</b>–<b>11</b>), and 5/6/8 (<b>13</b>) fused ring skeletons, sikkimenoid
E (<b>12</b>), and jatrointelones J-M (<b>14</b>–<b>17</b>) possessing jatropholane and lathyrane carbon skeletons,
respectively. Jatrointelones J (<b>14</b>) and M (<b>17</b>) represent the first naturally occurring examples of C-15 nonoxidized
lathyrane-type diterpenoids. The structures of the new compounds were
elucidated by NMR spectroscopic data analysis. The relative configuration
of compound <b>16</b> and the absolute configurations of compounds <b>3</b>–<b>6</b> and <b>14</b> were determined
by single-crystal X-ray diffraction analysis. In addition, jatrointelone
K (<b>15</b>) was chemically transformed to euphoractine T (<b>8</b>) supporting the biosynthetic relationships between the two
types of diterpenoids. Only compound <b>15</b> showed a moderate
anti-CHIKV activity with an EC<sub>50</sub> value of 14 μM.
Finally, using a molecular networking-based dereplication strategy,
several close analogues of 12-<i>O</i>-tetradecanoylphorbol-13-acetate
(TPA), one of the most potent inhibitors of CHIKV replication, were
dereplicated
Structurally Diverse Diterpenoids from Sandwithia guyanensis
Bioassay-guided fractionation of
an EtOAc extract of the trunk
bark of Sandwithia guyanensis, using
a chikungunya virus (CHIKV)-cell-based assay, afforded 17 new diterpenoids <b>1</b>–<b>17</b> and the known jatrointelones A and
C (<b>18</b> and <b>19</b>). The new compounds included
two tetranorditerpenoids <b>1</b> and <b>2</b>, a trinorditerpenoid <b>3</b>, euphoractines P-W (<b>4</b>–<b>11</b>), and euphactine G (<b>13</b>) possessing the rare 5/6/7/3
(<b>4</b>–<b>7</b>), 5/6/6/4 (<b>8</b>–<b>11</b>), and 5/6/8 (<b>13</b>) fused ring skeletons, sikkimenoid
E (<b>12</b>), and jatrointelones J-M (<b>14</b>–<b>17</b>) possessing jatropholane and lathyrane carbon skeletons,
respectively. Jatrointelones J (<b>14</b>) and M (<b>17</b>) represent the first naturally occurring examples of C-15 nonoxidized
lathyrane-type diterpenoids. The structures of the new compounds were
elucidated by NMR spectroscopic data analysis. The relative configuration
of compound <b>16</b> and the absolute configurations of compounds <b>3</b>–<b>6</b> and <b>14</b> were determined
by single-crystal X-ray diffraction analysis. In addition, jatrointelone
K (<b>15</b>) was chemically transformed to euphoractine T (<b>8</b>) supporting the biosynthetic relationships between the two
types of diterpenoids. Only compound <b>15</b> showed a moderate
anti-CHIKV activity with an EC<sub>50</sub> value of 14 μM.
Finally, using a molecular networking-based dereplication strategy,
several close analogues of 12-<i>O</i>-tetradecanoylphorbol-13-acetate
(TPA), one of the most potent inhibitors of CHIKV replication, were
dereplicated
Structurally Diverse Diterpenoids from Sandwithia guyanensis
Bioassay-guided fractionation of
an EtOAc extract of the trunk
bark of Sandwithia guyanensis, using
a chikungunya virus (CHIKV)-cell-based assay, afforded 17 new diterpenoids <b>1</b>–<b>17</b> and the known jatrointelones A and
C (<b>18</b> and <b>19</b>). The new compounds included
two tetranorditerpenoids <b>1</b> and <b>2</b>, a trinorditerpenoid <b>3</b>, euphoractines P-W (<b>4</b>–<b>11</b>), and euphactine G (<b>13</b>) possessing the rare 5/6/7/3
(<b>4</b>–<b>7</b>), 5/6/6/4 (<b>8</b>–<b>11</b>), and 5/6/8 (<b>13</b>) fused ring skeletons, sikkimenoid
E (<b>12</b>), and jatrointelones J-M (<b>14</b>–<b>17</b>) possessing jatropholane and lathyrane carbon skeletons,
respectively. Jatrointelones J (<b>14</b>) and M (<b>17</b>) represent the first naturally occurring examples of C-15 nonoxidized
lathyrane-type diterpenoids. The structures of the new compounds were
elucidated by NMR spectroscopic data analysis. The relative configuration
of compound <b>16</b> and the absolute configurations of compounds <b>3</b>–<b>6</b> and <b>14</b> were determined
by single-crystal X-ray diffraction analysis. In addition, jatrointelone
K (<b>15</b>) was chemically transformed to euphoractine T (<b>8</b>) supporting the biosynthetic relationships between the two
types of diterpenoids. Only compound <b>15</b> showed a moderate
anti-CHIKV activity with an EC<sub>50</sub> value of 14 μM.
Finally, using a molecular networking-based dereplication strategy,
several close analogues of 12-<i>O</i>-tetradecanoylphorbol-13-acetate
(TPA), one of the most potent inhibitors of CHIKV replication, were
dereplicated
Structurally Diverse Diterpenoids from Sandwithia guyanensis
Bioassay-guided fractionation of
an EtOAc extract of the trunk
bark of Sandwithia guyanensis, using
a chikungunya virus (CHIKV)-cell-based assay, afforded 17 new diterpenoids <b>1</b>–<b>17</b> and the known jatrointelones A and
C (<b>18</b> and <b>19</b>). The new compounds included
two tetranorditerpenoids <b>1</b> and <b>2</b>, a trinorditerpenoid <b>3</b>, euphoractines P-W (<b>4</b>–<b>11</b>), and euphactine G (<b>13</b>) possessing the rare 5/6/7/3
(<b>4</b>–<b>7</b>), 5/6/6/4 (<b>8</b>–<b>11</b>), and 5/6/8 (<b>13</b>) fused ring skeletons, sikkimenoid
E (<b>12</b>), and jatrointelones J-M (<b>14</b>–<b>17</b>) possessing jatropholane and lathyrane carbon skeletons,
respectively. Jatrointelones J (<b>14</b>) and M (<b>17</b>) represent the first naturally occurring examples of C-15 nonoxidized
lathyrane-type diterpenoids. The structures of the new compounds were
elucidated by NMR spectroscopic data analysis. The relative configuration
of compound <b>16</b> and the absolute configurations of compounds <b>3</b>–<b>6</b> and <b>14</b> were determined
by single-crystal X-ray diffraction analysis. In addition, jatrointelone
K (<b>15</b>) was chemically transformed to euphoractine T (<b>8</b>) supporting the biosynthetic relationships between the two
types of diterpenoids. Only compound <b>15</b> showed a moderate
anti-CHIKV activity with an EC<sub>50</sub> value of 14 μM.
Finally, using a molecular networking-based dereplication strategy,
several close analogues of 12-<i>O</i>-tetradecanoylphorbol-13-acetate
(TPA), one of the most potent inhibitors of CHIKV replication, were
dereplicated
Structurally Diverse Diterpenoids from Sandwithia guyanensis
Bioassay-guided fractionation of
an EtOAc extract of the trunk
bark of Sandwithia guyanensis, using
a chikungunya virus (CHIKV)-cell-based assay, afforded 17 new diterpenoids <b>1</b>–<b>17</b> and the known jatrointelones A and
C (<b>18</b> and <b>19</b>). The new compounds included
two tetranorditerpenoids <b>1</b> and <b>2</b>, a trinorditerpenoid <b>3</b>, euphoractines P-W (<b>4</b>–<b>11</b>), and euphactine G (<b>13</b>) possessing the rare 5/6/7/3
(<b>4</b>–<b>7</b>), 5/6/6/4 (<b>8</b>–<b>11</b>), and 5/6/8 (<b>13</b>) fused ring skeletons, sikkimenoid
E (<b>12</b>), and jatrointelones J-M (<b>14</b>–<b>17</b>) possessing jatropholane and lathyrane carbon skeletons,
respectively. Jatrointelones J (<b>14</b>) and M (<b>17</b>) represent the first naturally occurring examples of C-15 nonoxidized
lathyrane-type diterpenoids. The structures of the new compounds were
elucidated by NMR spectroscopic data analysis. The relative configuration
of compound <b>16</b> and the absolute configurations of compounds <b>3</b>–<b>6</b> and <b>14</b> were determined
by single-crystal X-ray diffraction analysis. In addition, jatrointelone
K (<b>15</b>) was chemically transformed to euphoractine T (<b>8</b>) supporting the biosynthetic relationships between the two
types of diterpenoids. Only compound <b>15</b> showed a moderate
anti-CHIKV activity with an EC<sub>50</sub> value of 14 μM.
Finally, using a molecular networking-based dereplication strategy,
several close analogues of 12-<i>O</i>-tetradecanoylphorbol-13-acetate
(TPA), one of the most potent inhibitors of CHIKV replication, were
dereplicated
Structurally Diverse Diterpenoids from Sandwithia guyanensis
Bioassay-guided fractionation of
an EtOAc extract of the trunk
bark of Sandwithia guyanensis, using
a chikungunya virus (CHIKV)-cell-based assay, afforded 17 new diterpenoids <b>1</b>–<b>17</b> and the known jatrointelones A and
C (<b>18</b> and <b>19</b>). The new compounds included
two tetranorditerpenoids <b>1</b> and <b>2</b>, a trinorditerpenoid <b>3</b>, euphoractines P-W (<b>4</b>–<b>11</b>), and euphactine G (<b>13</b>) possessing the rare 5/6/7/3
(<b>4</b>–<b>7</b>), 5/6/6/4 (<b>8</b>–<b>11</b>), and 5/6/8 (<b>13</b>) fused ring skeletons, sikkimenoid
E (<b>12</b>), and jatrointelones J-M (<b>14</b>–<b>17</b>) possessing jatropholane and lathyrane carbon skeletons,
respectively. Jatrointelones J (<b>14</b>) and M (<b>17</b>) represent the first naturally occurring examples of C-15 nonoxidized
lathyrane-type diterpenoids. The structures of the new compounds were
elucidated by NMR spectroscopic data analysis. The relative configuration
of compound <b>16</b> and the absolute configurations of compounds <b>3</b>–<b>6</b> and <b>14</b> were determined
by single-crystal X-ray diffraction analysis. In addition, jatrointelone
K (<b>15</b>) was chemically transformed to euphoractine T (<b>8</b>) supporting the biosynthetic relationships between the two
types of diterpenoids. Only compound <b>15</b> showed a moderate
anti-CHIKV activity with an EC<sub>50</sub> value of 14 μM.
Finally, using a molecular networking-based dereplication strategy,
several close analogues of 12-<i>O</i>-tetradecanoylphorbol-13-acetate
(TPA), one of the most potent inhibitors of CHIKV replication, were
dereplicated